Document Detail

Clinical and economic outcomes of embolic complications and strategies for distal embolic protection during percutaneous coronary intervention in saphenous vein grafts.
MedLine Citation:
PMID:  16446515     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Although distal embolic protection (DEP) is increasingly utilized in saphenous vein graft percutaneous coronary intervention (SVG PCI), the clinical and economic outcomes of different DEP strategies are unknown. METHODS: We compared 3 DEP strategies (no DEP, routine DEP, selective DEP in high-risk cases) in 126 consecutive cases of SVG PCI performed without DEP in a single catheterization laboratory over a 4-year period. No SVG PCI was excluded. High risk was defined using 2 multivariate predictors of embolic complication previously validated by NCDR (graft age greater than or equal to 8 years and or friable appearance with thrombus). Costs were determined by a ratio of cost-to-charges methodology and average cost of the two FDA-approved DEP devices ($1,350) with similar efficacy. RESULTS: Without DEP, the incidence of embolic complications was 17% (22/126), resulting in major adverse coronary events (MACE) in 3.2% (4/126) of all cases: 2 deaths, 1 myocardial infarction, and 1 emergency coronary artery bypass. Embolic complications significantly increased both procedure costs by $2,725 (p < .001) and total hospital costs approximately $2,800 (p < 0.05). Risk adjustment for selective DEP use correctly predicted 86% (19/22) of embolic complications, including all MACE, at an incremental cost of $684 per patient for selective DEP versus $1,150 per patient for routine DEP. Selective DEP would cost $43,127 per death prevented versus $72,461 using routine DEP during the index hospitalization. CONCLUSIONS: Embolic complications increase cost in excess of the cost of a DEP device. This risk adjustment model correctly predicted the majority of cases of embolic complication and all MACE, suggesting that selective DEP use may help reduce utilization of DEP by an almost 50% cost reduction compared to routine use.
Shaun R Senter; Sandeep Nathan; Akshay Gupta; Lloyd W Klein
Related Documents :
24477225 - Neonatal central venous catheter thrombosis: diagnosis, management and outcome.
24769885 - A device for performing automated balloon catheter inflation ischemia studies.
20304675 - Arterial embolization for the management of gastrointestinal hemorrhage from metastatic...
23777895 - Thoracic endovascular aortic repair with visceral arteries intermittent clamp technique...
8193965 - Schizencephaly: antenatal and postnatal assessment with colour-flow doppler imaging.
12027465 - The additional value of angiography after colour-coded duplex on decision making in pat...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  18     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-01-31     Completed Date:  2006-06-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  49-53     Citation Subset:  IM    
Section of Cardiology, Rush University Medical Center, Chicago, Illinois, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects*
Cohort Studies
Coronary Artery Bypass / adverse effects*
Costs and Cost Analysis
Embolism / economics*,  etiology*,  prevention & control
Graft Occlusion, Vascular / etiology,  therapy*
Health Care Costs*
Middle Aged
Preventive Medicine / methods
Retrospective Studies
Saphenous Vein / transplantation*
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Early ambulation and variability in anticoagulation during elective coronary stenting with a single ...
Next Document:  Percutaneous transvenous mitral commissurotomy using metallic commissurotome: long-term follow-up re...